Gemmill JD[au] - Search Results

Year	Number of Results
1987	1
1988	2
1990	1
1991	4
1992	2
1993	4
1994	1
2023	0

1

Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man.

MacFadyen RJ, Lees KR, Gemmill JD, Hillis WS, Reid JL. MacFadyen RJ, et al. Among authors: gemmill jd. Br J Clin Pharmacol. 1991 Aug;32(2):193-9. doi: 10.1111/j.1365-2125.1991.tb03881.x. Br J Clin Pharmacol. 1991. PMID: 1657093 Free PMC article.

2

A comparison of the pharmacokinetic properties of streptokinase and anistreplase in acute myocardial infarction.

Gemmill JD, Hogg KJ, Burns JM, Rae AP, Dunn FG, Fears R, Ferres H, Standring R, Greenwood H, Pierce D, et al. Gemmill JD, et al. Br J Clin Pharmacol. 1991 Feb;31(2):143-7. doi: 10.1111/j.1365-2125.1991.tb05502.x. Br J Clin Pharmacol. 1991. PMID: 2049230 Free PMC article. Clinical Trial.

3

Secretor state of patients with insulin dependent or non-insulin-dependent diabetes mellitus.

Blackwell CC, James VS, Weir DM, Gemmill JD, Patrick AW, Collier A, Clarke BF. Blackwell CC, et al. Among authors: gemmill jd. Br Med J (Clin Res Ed). 1987 Oct 24;295(6605):1024-5. doi: 10.1136/bmj.295.6605.1024. Br Med J (Clin Res Ed). 1987. PMID: 3120855 Free PMC article. No abstract available.

4

Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction.

Hogg KJ, Gemmill JD, Burns JM, Lifson WK, Rae AP, Dunn FG, Hillis WS. Hogg KJ, et al. Among authors: gemmill jd. Lancet. 1990 Feb 3;335(8684):254-8. doi: 10.1016/0140-6736(90)90069-h. Lancet. 1990. PMID: 1967720 Clinical Trial.

5

Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase.

Gemmill JD, Hogg KJ, Dunn FG, Rae AP, Hillis WS. Gemmill JD, et al. Br Heart J. 1994 Sep;72(3):222-5. doi: 10.1136/hrt.72.3.222. Br Heart J. 1994. PMID: 7946770 Free PMC article.

6

A dose-ranging study of UK-68,798, a novel class III anti-arrhythmic agent, in normal volunteers.

Gemmill JD, Howie CA, Meredith PA, Kelman AW, Rasmussen HS, Hillis WS, Elliott HL. Gemmill JD, et al. Br J Clin Pharmacol. 1991 Oct;32(4):429-32. doi: 10.1111/j.1365-2125.1991.tb03926.x. Br J Clin Pharmacol. 1991. PMID: 1958435 Free PMC article. Clinical Trial.

7

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation.

MacIntyre PD, Bhargava B, Hogg KJ, Gemmill JD, Hillis WS. MacIntyre PD, et al. Among authors: gemmill jd. Circulation. 1993 Feb;87(2):401-5. doi: 10.1161/01.cir.87.2.401. Circulation. 1993. PMID: 8381056

8

The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation.

Macintyre PD, Bhargava B, Hogg KJ, Gemmill JD, Hillis WS. Macintyre PD, et al. Among authors: gemmill jd. Br J Clin Pharmacol. 1992 Dec;34(6):541-6. Br J Clin Pharmacol. 1992. PMID: 1337261 Free PMC article.

9

The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents--lack of relationship to pretreatment streptokinase resistance.

Gemmill JD, Hogg KJ, Douglas JT, Dunn FG, Lowe GD, Rae AP, Hillis WS. Gemmill JD, et al. Eur Heart J. 1993 Jun;14(6):819-25. doi: 10.1093/eurheartj/14.6.819. Eur Heart J. 1993. PMID: 8325311 Clinical Trial.

10

Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.

Fears R, Ferres H, Glasgow E, Standring R, Hogg KJ, Gemmill JD, Burns JM, Rae AP, Dunn FG, Hillis WS. Fears R, et al. Among authors: gemmill jd. Br Heart J. 1992 Aug;68(2):167-70. doi: 10.1136/hrt.68.8.167. Br Heart J. 1992. PMID: 1389731 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results